Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1983 1
1986 3
1987 1
1988 1
1989 1
1990 4
1991 2
1992 2
1993 7
1994 7
1995 4
1996 6
1997 4
1998 4
1999 14
2000 4
2001 4
2002 6
2003 10
2004 14
2005 31
2006 26
2007 29
2008 38
2009 43
2010 62
2011 73
2012 114
2013 123
2014 147
2015 136
2016 128
2017 131
2018 168
2019 185
2020 207
2021 233
2022 151
Text availability
Article attribute
Article type
Publication date

Search Results

1,902 results
Results by year
Filters applied: . Clear all
Page 1
Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial.
Chen X, Wu X, Wu H, Gu Y, Shao Y, Shao Q, Zhu F, Li X, Qian X, Hu J, Zhao F, Mao W, Sun J, Wang J, Han G, Li C, Xia Y, Seesaha PK, Zhu D, Li H, Zhang J, Wang G, Wang X, Li X, Shu Y. Chen X, et al. Among authors: shao q. J Immunother Cancer. 2020 Nov;8(2):e001240. doi: 10.1136/jitc-2020-001240. J Immunother Cancer. 2020. PMID: 33172881 Free PMC article. Clinical Trial.
Biologic therapy in Sjögren's syndrome.
Shao Q. Shao Q. Clin Rheumatol. 2021 Jun;40(6):2143-2154. doi: 10.1007/s10067-020-05429-1. Epub 2020 Oct 27. Clin Rheumatol. 2021. PMID: 33106929 Review.
1,902 results